(Q45537024)

14 December 2017

title

Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses (English)

1 reference

14 December 2017

2

Craig J Gerard

1 reference

14 December 2017

Alison E John

1

1 reference

14 December 2017

Matthew Schaller

3

1 reference

14 December 2017

Allison L Miller

4

1 reference

14 December 2017

Aaron A Berlin

5

1 reference

14 December 2017

Allison A Humbles

6

1 reference

14 December 2017

Nicholas W Lukacs

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

European Journal of Immunology

14 December 2017

published in

1 reference

14 December 2017

volume

35

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

108-116

1 reference

Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Syndrome of Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA)—What it isn’t. What is it?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

RSV and chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Gene expression in epithelial cells in response to pneumovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Epidemiology of chronic obstructive pulmonary disease (COPD).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Lung function outcome in children of premature birth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Childhood antecedents of adult respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

The Childhood Origins of Asthma (COAST) study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Latency and persistence of respiratory syncytial virus despite T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425439

7 January 2021

Identifiers

DOI

10.1002/EJI.200425439

1 reference

14 December 2017

1 reference